Next Article in Journal
Genetic and Environmental Factors Contributing to the Pathogenesis of Vertebral Osteomyelitis Caused by Enterococcus cecorum in Broiler Chicken
Previous Article in Journal
Pharmacokinetics of Tolfenamic Acid Administered Orally and Intravenously at Different Doses in Pekin Ducks (Anas platyrhynchos domestica)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effects of Dietary Baicalin on Aflatoxin B1-Induced Growth Performance and Liver Health in Ducklings

1
Hubei Key Laboratory of Animal Nutrition and Feed Science, School of Animal Science and Nutritional Engineering, Wuhan Polytechnic University, Wuhan 430023, China
2
Wuhan Engineering and Technology Research Center of Animal Disease-Resistant Nutrition, School of Animal Science and Nutritional Engineering, Wuhan Polytechnic University, Wuhan 430023, China
3
National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Animals 2025, 15(16), 2325; https://doi.org/10.3390/ani15162325
Submission received: 12 July 2025 / Revised: 2 August 2025 / Accepted: 5 August 2025 / Published: 8 August 2025

Simple Summary

Aflatoxin B1 (AFB1), a toxic compound commonly found in contaminated animal feed, can severely damage liver health and reduce growth performance in ducklings. This study explored whether baicalin, a natural flavonoid from Scutellaria baicalensis, could protect against such damage. The results showed that dietary baicalin effectively improved liver function, reduced harmful enzyme levels, and boosted overall performance in AFB1-exposed ducklings. These findings suggest baicalin may serve as a beneficial feed additive in poultry production to combat aflatoxin toxicity.

Abstract

Aflatoxin B1 (AFB1) is a highly toxic secondary metabolite produced by Aspergillus species. Its extensive contamination of animal feed and human food poses significant health hazards to livestock and humans, with hepatotoxicity being a primary concern. This study investigated the protective effect of baicalin on AFB1-induced liver injury in ducklings. In the first experiment, ducklings were administered AFB1 at doses of 0, 6, 12, or 24 μg/kg body weight/day for 7 days to identify the optimal concentration for establishing a model of AFB1-induced growth performance and liver injury. Administration of AFB1, particularly at the higher doses (12 and 24 μg/kg body weight/day), significantly reduced growth performance and induced structural and functional liver injury (p < 0.05). In a second experiment, ducklings were administered AFB1 (12 μg/kg body weight/day) with or without baicalin (25–100 mg/kg body weight/day) for 7 days. Dietary baicalin significantly increased the serum albumin level; reduced the serum alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transferase levels; improved growth performance; and ameliorated structural and functional liver injury in ducklings exposed to AFB1 (p < 0.05). The results indicate that dietary baicalin alleviates AFB1-induced liver injury and growth performance decline in ducklings. Hence, baicalin could serve as a potential feed additive to reduce the harmful effects of AFB1 in the poultry breeding industry.

1. Introduction

Aflatoxin B1 (AFB1) is a secondary metabolite produced by Aspergillus species [1,2]. As the most toxic aflatoxin subtype in feed, AFB1 seriously affects the health of livestock and poultry, and causes huge economic losses to livestock and poultry [3]. In one study, the authors analyzed the concentration of AFB1 in 74,821 feeds and feed raw materials collected from 100 countries from 2008 to 2017. The analysis revealed the global presence of AFB1 in 74,821 feeds and feed raw materials [4]. AFB1-contaminated feed consumed by livestock and poultry can cause liver injury, as the liver is the target organ for toxin activation, metabolism, and elimination [5]. AFB1 in contaminated feed consumed by livestock and poultry accumulates in the liver and can be transmitted to humans through the food chain, posing a serious threat to animals and humans [6,7]. A previous study has reported that feeding 1-day-old ducks with a basal diet supplemented with 90 μg/kg AFB1 for 4 weeks resulted in significant body weight loss and severe hepatotoxicity [8]. Another study has reported that feeding nursery pigs continuously with 0.5 mg/kg AFB1 in the basal diet for 20 days decreased the growth rate and feed intake, accompanied by an increase in the levels of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) [9]. Additionally, a study has reported that dietary consumption of 0.1 mg/kg AFB1 for 21 days significantly decreased the growth performance and hepatic function of broilers [10]. Furthermore, research has shown that female mutton sheep consuming a diet supplemented with 75 μg AFB1/kg dry matter for 30 days exhibited significant reductions in average daily feed intake (ADFI) and significant increases in serum ALT and AST levels [11]. Based on the aforementioned studies, dietary AFB1 exposure significantly impairs growth performance and liver function in livestock and poultry. Consequently, strategies to determine and mitigate the detrimental AFB1-induced effects in livestock and poultry have become a major focus of contemporary research [12,13,14,15].
Baicalin, a bioactive flavonoid compound extracted from Scutellaria baicalensis, has garnered considerable research attention due to its broad spectrum of pharmacological properties, including antimicrobial, anti-apoptotic, anti-inflammatory, antioxidant, and hepatoprotective activities [16,17,18]. In a model of duck liver injury induced by duck hepatitis A virus type 1, baicalin (3 mg/kg body weight) significantly increased the survival rate of ducklings and reduced hepatic mitochondrial dysfunction [19]. In a chicken liver injury model induced by zearalenone, baicalin (20, 40, or 80 mg/kg body weight) significantly reduced the serum levels of AST and ALT and inhibited the inflammatory response, apoptosis, and oxidative stress in the liver [20]. Moreover, in in vitro models, baicalin has been shown to alleviate hepatocyte injury caused by AFB1 via apoptosis and ferroptosis [21,22]. Therefore, baicalin supplementation has the potential to protect the liver from AFB1-related injury, but its utility as a feed additive for ducklings warrants in vivo validation in ducklings.
This study aimed to establish an experimental model of AFB1-induced liver injury in ducklings and to evaluate the hepatoprotective efficacy of dietary baicalin supplementation against this mycotoxin-mediated injury. The findings establish a theoretical foundation for the potential application of dietary baicalin supplementation to mitigate AFB1-induced health impairments in livestock and poultry.

2. Materials and Methods

2.1. Chemicals

Baicalin (CAS No.: 21967-41-9) was obtained from Chengdu Biopurify Phytochemicals Ltd. (Chengdu, China). AFB1 (CAS No.: 1162-65-8) was obtained from Qingdao Pribolab Biological Engineering Co., Ltd. (Qingdao, China).

2.2. Animal Experiment Design

In both study parts, one-day-old Liangping ducklings were purchased from the Changfeng Hatchery (Xiaonan District, Xiaogan City, China). One week prior to the experiment, the duck house and cages were thoroughly cleaned and rinsed. Subsequently, the duck house was sealed and fumigated with potassium permanganate and formaldehyde for disinfection. Following a 3-day fumigation period, the house was ventilated for 4 days. To ensure duckling comfort and minimize stress, the heating system maintained an ambient temperature of 34 °C for ducklings aged 1 to 3 days. The temperature was then gradually reduced to reach the target ambient temperature required for ducklings aged 4 to 14 days. Consistent nutritional conditions were maintained, with all ducklings across treatment groups receiving the identical basal diet. All ducklings were fed the same basic diet from days 1 to 3 of age.
In the first part of the study, 20 one-day-old Liangping ducklings were used. Beginning on day 4, the 20 ducklings were randomly divided into four groups (n = 5/group): one control group and three AFB1 challenge groups, specifically a low dose at 6 μg/kg body weight/day, a medium dose at 12 μg/kg body weight/day, and a high dose at 24 μg/kg body weight/day. Beginning on day 4, the ducklings were administered vehicle (control group) or AFB1 once a day for 7 consecutive days. All ducklings could freely eat and drink. After each feeding, the feeding, drinking, and activity of the ducklings were carefully observed, and the feed intake was accurately recorded. The dose of AFB1 were chosen based on previous studies that indicated exposure to 10–40 μg/kg AFB1 can significantly induce liver injury and affect the growth performance of ducklings [23,24], and the China national feed hygiene standard GB 13078-2017 stipulates that the maximum permissible concentration of AFB1 in feed for meat ducks and laying ducks is 15 μg/kg [25]. The animal experiments were approved by the Animal Ethics Committee of Wuhan Polytechnic University (permit number WPU202404003).
The medium AFB1 dose (12 μg/kg body weight/day) caused severe liver injury in ducklings, so this dose was selected for the second part of the study. Sixty 1-day-old Liangping ducklings were used. On day 4, the ducklings were randomly divided into six groups (n = 10/group): the control group, the AFB1 group (12 μg/kg body weight/day AFB1), the AFB1 + low-dose baicalin group (12 μg/kg body weight/day AFB1 + 25 mg/kg body weight/day baicalin), the AFB1 + medium-dose baicalin group (12 μg/kg body weight/day AFB1 + 50 mg/kg body weight/day baicalin), and the AFB1 + high-dose baicalin group (12 μg/kg body weight/day AFB1 + 100 mg/kg body weight/day baicalin). Baicalin was administered daily via oral gavage from day 4 until trial termination. Beginning on day 7, the ducklings in the AFB1 group received the AFB1 solution once a day for 7 consecutive days via oral gavage. The dose of baicalin was chosen based on previous studies that the hepatoprotective effects of baicalin against various toxins have utilized doses within the range of 25–200 mg/kg body weight [26,27,28,29]. All ducklings could freely feed and drink. After each feeding, the feeding, drinking, and activity behaviors of the ducklings were carefully observed, and the feed intake was accurately recorded. The animal experiments were approved by the Animal Ethics Committee of Wuhan Polytechnic University (permit number WPU202406002).

2.3. Serum Biochemical Assay

For the biochemical parameters, heparinized blood samples were centrifuged at 3500 rpm for 10 min to collect serum. An automatic blood biochemical analyzer (HITACHI 7100, Hitachi, Tokyo, Japan) was used to determine the serum albumin (ALB), ALT, AST, and gamma-glutamyl transferase (GGT) levels.

2.4. Histopathological Observation

After collecting liver samples from the ducklings, they were fixed in 4% paraformaldehyde (Servicebio, Wuhan, China). After embedding in paraffin, the samples were sectioned and stained with hematoxylin and eosin (H&E) by Wuhan Pigeonbio Technology Co., Ltd. (Wuhan, China). The histopathological changes in liver tissues were observed using a microscope and an imaging system (Nikon, Tokyo, Japan).

2.5. Statistical Analysis

Statistical analysis was performed using SPSS Statistics 19.0 for Windows (IBM Corp., Armonk, NY, USA). The data are presented as the mean and standard error of the mean. One-way analysis of variance was used to analyze the data, followed by Duncan’s post hoc analysis, with p < 0.05 indicating a significant difference between groups and p < 0.01 indicating a highly significant difference.

3. Results

3.1. Growth Performance of Ducklings Exposed to Different Doses of AFB1

Table 1 shows the effects of different AFB1 doses on the growth performance of ducklings. Compared with the control group, the average daily gain (ADG) of ducklings in the 12 and 24 μg/kg body weight/day groups was significantly reduced (p < 0.05), and the ADFI showed a decreasing trend, but there was no significant difference between the groups (p > 0.05). Meanwhile, the feed-to-gain ratio (FCR) was not significantly different between the groups (p > 0.05). Intake of 12 and 24 μg/kg body weight/day AFB1 had a significant inhibitory effect on the growth of ducklings, while intake of 6 μg/kg body weight/day AFB1 did not.

3.2. The Effect of Different Doses of AFB1 on Liver Histopathology of Ducklings

Figure 1 shows images of H&E-stained liver samples from the ducklings. In the control group (Figure 1A), the liver tissue structure was normal, the hepatocytes were arranged neatly without obvious cell degeneration, the liver lobules were clearly visible and structurally intact, the hepatocytes centered on the portal vein were arranged radially, and the nucleoli were large and clear. Compared with the control group, there was granular degeneration of hepatocytes or steatosis in the 6 μg/kg body weight/day AFB1 group (Figure 1B). In the 12 μg/kg body weight/day AFB1 group (Figure 1C), the liver showed a disordered arrangement of hepatocyte cords, most hepatocytes had undergone granular degeneration and steatosis, and there was focal hepatocyte necrosis. In the 24 μg/kg body weight/day AFB1 group (Figure 1D), most hepatocytes had undergone granular degeneration or steatosis, and many hepatocytes had undergone necrosis. Overall, 6 μg/kg body weight/day AFB1 caused less intense liver injury in ducklings compared with the two higher concentrations.

3.3. The Effect of Baicalin on Growth Performance of AFB1-Exposed Ducklings

Table 2 presents the effects of baicalin on the growth performance of AFB1-exposed ducklings. Compared with the control group, the ADG was significantly decreased in the AFB1 group (p < 0.05). There was no significant difference in the ADFI and FCR between control and AFB1 groups (p > 0.05). Compared with the AFB1 group, the ADG was significantly increased in the AFB1 + 100 mg/kg body weight/day baicalin group (p < 0.05). Compared with the AFB1 group, the FCR was significantly reduced in the AFB1 + 100 mg/kg body weight/day baicalin group (p < 0.05). Overall, AFB1 challenge significantly reduced ADG, and the addition of 100 mg/kg body weight/day baicalin after this challenge significantly restored growth performance.

3.4. The Effect of Baicalin on Serum Biochemical Parameters of AFB1-Exposed Ducklings

The serum levels of ALB, ALT, AST, and GGT were used as indicators of liver injury (Table 3). Compared with the control group, the AFB1 group exhibited a significant decrease in serum ALB (p < 0.05) and significant increases in serum AST, ALT, and GGT (p < 0.05). Compared with the AFB1 group, all baicalin treatment groups (25, 50, and 100 mg/kg body weight/day) significantly increased serum ALB (p < 0.05) and significantly decreased serum ALT and AST (p < 0.05). Notably, the higher dose of baicalin (100 mg/kg body weight/day) additionally induced a significant decrease in serum GGT (p < 0.05). These data indicate that baicalin protected ducklings against AFB1-induced liver injury.

3.5. The Effect of Baicalin on Liver Histopathological Changes in AFB1-Exposed Ducklings

Figure 2 shows the effect of baicalin on the histopathological changes in the liver of AFB1-exposed ducklings. In the control group (Figure 2A), the liver tissue showed a normal structure, with neatly arranged hepatocytes without obvious cell degeneration, clearly visible and structurally intact liver lobules, the hepatocytes centered on the portal vein were arranged radially, and large and clear nucleoli. The AFB1 group (Figure 2B) presented a disordered arrangement of hepatocyte cords, and most hepatocytes had undergone granular degeneration and steatosis, with focal hepatocyte necrosis. Compared with the AFB1 group, the AFB1 + 25 mg/kg body weight/day baicalin group (Figure 2C) showed no obvious changes in the liver structure, although most hepatocytes had undergone granular degeneration or steatosis, and a few hepatocytes had undergone necrosis. In the AFB1 + 50 mg/kg body weight/day baicalin group (Figure 2D), vacuolar degeneration and steatosis of hepatocytes were reduced, and there was less extensive hepatocyte granular degeneration or steatosis. There was significantly improved hepatocyte degeneration in the AFB1 + 100 mg/kg body weight/day baicalin group (Figure 2E), with no significant difference in hepatocytes compared with the control group. Taken together, administration of 50 and 100 mg/kg body weight/day baicalin alleviated AFB1-induced liver injury in ducklings, with the higher dose producing better results.

4. Discussion

AFB1 is a very common mycotoxin in feed; it contaminates a wide range of feed and feed raw materials and thus poses a serious threat to the health of livestock and poultry [3,30,31]. Exposure to AFB1 can seriously affect the growth performance of livestock and poultry and lead to hepatoxicity [32,33,34]. Natural products and dietary supplements have been shown to alleviate the injury caused by AFB1 exposure [35,36,37]. It is of great clinical significance to study the growth performance and hepatotoxicity caused by AFB1 exposure in ducklings and the regulatory effects of natural products. Thus, we investigated the protective effect of baicalin against AFB1-induced liver injury and growth performance decline in ducklings. We found that dietary baicalin significantly improved the growth performance and liver histopathological changes in ducklings exposed to AFB1.
AFB1 is a prevalent contaminant in agricultural products, presenting significant risks to the growth performance of livestock and poultry, including ducks [24]. In a previous study, challenge with 20 μg/kg body weight AFB1 significantly decreased the body weight and ADG of male Pekin ducklings [24]. In another study, compared with the control group, 7-day-old Cherry Valley ducklings fed 0.1 mg AFB1/kg exhibited a reduction in the final body weight and the ADG, and a poor FCR during a 42-day trial [38]. One-day-old Cherry Valley ducklings challenged with 120.02 μg/kg AFB1 presented a significant reduction in the ADG and ADFI and an increase in mortality during days 0–14, while 153.12 μg/kg AFB1 challenge did not affect the FCR during days 15–35 [39]. Consistent with these results, we found that the ADG of ducklings exposed to 12 or 24 μg/kg body weight/day AFB1 for 7 days decreased significantly and dose dependently, and the ADFI showed a trend for a decrease. The findings from previous studies and our study imply that feeding ducklings AFB1-contaminated feed can affect growth performance, so it is critical to seek interventions to reduce the impact of AFB1 on growth performance.
Baicalin is a flavonoid extracted from S. baicalensis with a variety of pharmacological effects, including antitumor, antiviral, antibacterial, neuroprotective, and especially hepatoprotective [16,40,41,42]. Meanwhile, the extract of S. baicalensis (containing ≥85% baicalin) demonstrates potential as a feed additive to enhance livestock and poultry growth performance [43]. Based on this, it is anticipated that baicalin can be developed as a feed additive for application in animal production. We found that 100 mg/kg body weight/day baicalin significantly decreased the FCR and increased the ADG in AFB1-exposed ducklings. Abnormal serum levels of ALB, ALT, AST, and GGT have been reported as indicators of hepatotoxicity [44,45]. After treatment with baicalin, the ALT and AST levels in ducklings infected with duck hepatitis A virus type 1 were significantly reduced [19,46], demonstrating the hepatoprotective effect of baicalin. In rats, baicalin attenuated the AFB1-induced increase in serum ALT and AST and hepatocyte injury [22]. In addition, baicalin treatment significantly reduced the levels of ALT, AST, and GGT in a rat model of ulcerative colitis, thereby alleviating liver injury [47]. Consistently, we found that baicalin significantly reduced serum AST, ALT, and GGT and increased serum ALB in ducklings after AFB1 challenge. These biochemical changes were accompanied by a reduction in AFB1-induced liver injury.
The liver is the most important detoxification organ for AFB1, and it is also the target organ of this toxin [48,49]. Liver histopathological changes are the key indicators of AFB1-mediated toxicity [50,51]. A previous study reported that supplementing the basal diet with 50 μg/kg AFB1 caused severe liver injury in ducks, including vacuolar degeneration, inflammatory cell infiltration, cell necrosis, and swelling [44]. In another study, H&E staining of the liver of ducklings exposed to 0.1 mg/kg AFB1 showed a disordered hepatic cord—it sometimes even disappeared—and the hepatocytes appeared to have undergone vacuolization and steatosis [52]. One-day-old Sichuan Sheldrakes exposed to 100 μg/kg AFB1 showed obvious destruction of liver lobule structure, obvious vacuolar degeneration of hepatocytes, distorted cell structure, nuclear pyknosis, obvious inflammatory cell infiltration, and partial cell degeneration and necrosis [53]. Consistently, the AFB1-challenged ducklings in the present study showed a disordered arrangement of hepatocyte cords, granular degeneration and steatosis of most hepatocytes, and focal hepatocyte necrosis. Previous studies indicated that AFB1 exposure induces multifaceted liver injury in ducklings, including oxidative stress via suppression of the nuclear factor erythroid 2-related factor 2-heme oxygenase 1 pathway [7,44,54], inflammatory injury mediated by nod-like receptor protein 3 inflammasome activation [5,55], and apoptosis triggered by pro-apoptotic signaling [33,54]. The present study showed that baicalin significantly protected against AFB1-induced histopathological changes in the liver. However, the molecular mechanism underlying this protective effect, such as potential roles of antioxidative, anti-inflammatory, and anti-apoptotic pathways, requires further elucidation.
However, this study has several limitations. First, the molecular mechanisms by which baicalin alleviates AFB1-induced liver injury require comprehensive elucidation in both in vivo models (specifically ducklings) and in vitro systems. Second, the protective efficacy of baicalin against AFB1-induced liver injury warrants verification across diverse duck breeds and other poultry species. Third, the impact of AFB1–baicalin interactions on gut microbiota dysbiosis, a critical modulator of hepatotoxicity, remains unexplored. Fourth, the long-term protective efficacy of baicalin remains unassessed.

5. Conclusions

We found that dietary baicalin reduced AFB1-induced liver injury, denoted by a reduction in serum biochemical indicators of liver injury and liver pathological changes. These findings indicate that baicalin is an effective feed additive that can potentially protect ducklings from AFB1-induced liver injury by improving growth performance and reducing liver injury. Its use for the safe production of livestock and poultry could reduce the economic losses caused by AFB1 contamination.

Author Contributions

Conceptualization, Q.L., J.X., and Y.Q.; methodology, X.Z., J.Z., and J.X.; software, J.Z. and J.X.; validation, X.Z. and J.X.; formal analysis, X.Z. and J.Z.; investigation, Q.L., X.Z., and J.Z.; data curation, X.Z., X.W., D.W., P.G., and J.X.; writing—original draft preparation, Q.L., X.Z., and J.X.; writing—review and editing, J.Z., X.W., D.W., P.G., and Y.Q.; visualization, J.Z. and P.G.; supervision, J.X.; project administration, J.X. and Y.Q.; funding acquisition, J.X. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Open Project of Hubei Key Laboratory of Animal Nutrition and Feed Science (202313).

Institutional Review Board Statement

The procedures in this study were approved by the Animal Ethics Committee of Wuhan Polytechnic University under permit numbers WPU202404003 (18 April 2024) and WPU202406002 (3 June 2024).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in the article.

Acknowledgments

We thank our laboratory colleagues for their assistance with the animal experiments.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
ADFIAverage daily feed intake
ADGAverage daily gain
AFB1Aflatoxin B1
ALBAlbumin
ALTAlanine aminotransferase
ASTAspartate aminotransferase
FCRFeed-to-gain ratio
GGTGamma-glutamyltransferase
H&EHematoxylin and eosin

References

  1. Wu, S.; Feng, K.; Niu, J.; Xu, J.; Mo, H.; She, X.; Yu, S.B.; Li, Z.T.; Yan, S. Acyclic cucurbit[n]uril-enabled detection of aflatoxin b1 via host-guest chemistry and bioluminescent immunoassay. Toxins 2025, 17, 104. [Google Scholar] [CrossRef]
  2. Lu, Q.; Hu, Y.; Nabi, F.; Li, Z.; Janyaro, H.; Zhu, W.; Liu, J. Effect of penthorum chinense pursh compound on afb1-induced immune imbalance via jak/stat signaling pathway in spleen of broiler chicken. Vet. Sci. 2023, 10, 521. [Google Scholar] [CrossRef]
  3. Rushing, B.R.; Selim, M.I. Aflatoxin b1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods. Food Chem. Toxicol. 2019, 124, 81–100. [Google Scholar] [CrossRef]
  4. Gruber-Dorninger, C.; Jenkins, T.; Schatzmayr, G. Global mycotoxin occurrence in feed: A ten-year survey. Toxins 2019, 11, 375. [Google Scholar] [CrossRef] [PubMed]
  5. Jin, S.; Yang, H.; Wang, Y.; Pang, Q.; Jiao, Y.; Shan, A.; Feng, X. Dietary curcumin alleviated aflatoxin b1-induced acute liver damage in ducks by regulating nlrp3-caspase-1 signaling pathways. Foods 2021, 10, 3086. [Google Scholar] [CrossRef]
  6. Limaye, A.; Yu, R.C.; Chou, C.C.; Liu, J.R.; Cheng, K.C. Protective and detoxifying effects conferred by dietary selenium and curcumin against afb1-mediated toxicity in livestock: A review. Toxins 2018, 10, 25. [Google Scholar] [CrossRef] [PubMed]
  7. Qiao, B.; He, Y.; Gao, X.; Liu, H.; Rao, G.; Su, Q.; Ruan, Z.; Tang, Z.; Hu, L. Curcumin attenuates afb1-induced duck liver injury by inhibiting oxidative stress and lysosomal damage. Food Chem. Toxicol. 2023, 172, 113593. [Google Scholar] [CrossRef]
  8. Yu, A.; Wang, H.; Cheng, Q.; Rajput, S.A.; Qi, D. The effects of aflatoxin b(1) on liver cholestasis and its nutritional regulation in ducks. Toxins 2024, 16, 239. [Google Scholar] [CrossRef] [PubMed]
  9. Tarasconi, L.; Dazuk, V.; Molosse, V.L.; Cécere, B.G.O.; Deolindo, G.L.; Mendes, R.E.; Gloria, E.M.; Ternus, E.M.; Galli, G.M.; Paiano, D.; et al. Nursery pigs fed with feed contaminated by aflatoxin b1 (aspergillus flavus) and anti-mycotoxin blend: Pathogenesis and negative impact on animal health and weight gain. Microb. Pathog. 2024, 186, 106474. [Google Scholar] [CrossRef]
  10. Ye, X.; Yang, Y.; Yao, Q.; Huang, M.; Balasubramanian, B.; Jha, R.; Liu, W. The ameliorative role of phlorotannin on aflatoxin b(1)-induced liver oxidative stress and mitochondrial injury is related to the activation of nrf2 and nrf1 signaling pathways in broilers. J. Anim. Sci. Biotechnol. 2025, 16, 75. [Google Scholar] [CrossRef]
  11. Zhang, M.; Jiao, P.; Wang, X.; Sun, Y.; Liang, G.; Xie, X.; Zhang, Y. Evaluation of growth performance, nitrogen balance and blood metabolites of mutton sheep fed an ammonia-treated aflatoxin b1-contaminated diet. Toxins 2022, 14, 361. [Google Scholar] [CrossRef] [PubMed]
  12. Sarwar, M.K.; ul Haq, I.; Ijaz, S.; Javed, N.; Akbar, N. Molecular and analytical approaches based characterization of aflatoxins producing aspergillus species affecting groundnut. Pak. J. Agr. Sci. 2024, 61, 931–940. [Google Scholar]
  13. Saleemi, M.K.; Raza, A.; Khatoon, A.; Zubair, M.; Xu, Y.P.; Murtaza, B.; Li, X.Y.; Jamil, M.; Imran, M.; Muhammad, F.; et al. Toxic effects of aflatoxin b1 on hematobiochemical and histopathological parameters of juvenile white leghorn male birds and their amelioration with vitamin e and moringa oleifera. Pak. Vet. J. 2023, 43, 405–411. [Google Scholar]
  14. Tarhane, S.; Dursun, I.; Mor, B.; Tarhane, A.K.; Kiziltepe, S.; Filazi, I.; Güven, A. Determination of the mycotoxin activity of filamentous fungi isolated from the intestinal region of adult honey bees by the pcr and uhplc-orbitrap-hrms methods. Kafkas Univ. Vet. Fak. 2023, 29, 473–481. [Google Scholar] [CrossRef]
  15. Sadimantara, M.S.; Argo, B.D.; Sucipto, S.; Hendrawan, Y. Prediction of aflatoxin contamination in cocoa beans using uv-fluorescence imaging and artificial neural networks for enhanced detection. J. Glob. Innov. Agric. Sci. 2024, 12, 315–325. [Google Scholar] [CrossRef]
  16. Yang, J.Y.; Li, M.; Zhang, C.L.; Liu, D. Pharmacological properties of baicalin on liver diseases: A narrative review. Pharmacol. Rep. 2021, 73, 1230–1239. [Google Scholar] [CrossRef]
  17. Jiang, M.; Li, Z.; Qin, X.; Chen, L.; Zhu, G. Regulatory role of flavonoid baicalin from scutellaria baicalensis on ampk: A review. Am. J. Chin. Med. 2025, 53, 771–801. [Google Scholar] [CrossRef]
  18. Wen, Y.; Wang, Y.; Zhao, C.; Zhao, B.; Wang, J. The pharmacological efficacy of baicalin in inflammatory diseases. Int. J. Mol. Sci. 2023, 24, 9317. [Google Scholar] [CrossRef]
  19. Su, L.; Wang, R.; Qiu, T.; Wang, J.; Meng, J.; Zhu, J.; Wang, D.; Wu, Y.; Liu, J. The protective effect of baicalin on duck hepatitis a virus type 1-induced duck hepatic mitochondria dysfunction by activating nuclear erythroid 2-related factor 2/antioxidant responsive element signaling pathway. Poult. Sci. 2021, 100, 101032. [Google Scholar] [CrossRef] [PubMed]
  20. Xu, J.; Li, S.; Jiang, L.; Gao, X.; Liu, W.; Zhu, X.; Huang, W.; Zhao, H.; Wei, Z.; Wang, K.; et al. Baicalin protects against zearalenone-induced chicks liver and kidney injury by inhibiting expression of oxidative stress, inflammatory cytokines and caspase signaling pathway. Int. Immunopharmacol. 2021, 100, 108097. [Google Scholar] [CrossRef] [PubMed]
  21. Wen, D.; Zhang, J.; Zhou, H.; Qiu, Y.; Guo, P.; Lu, Q.; Xiong, J. Baicalin attenuates aflatoxin b(1)-induced hepatotoxicity via suppressing c-jun-n-terminal kinase-mediated cell apoptosis. Mycotoxin Res. 2024, 40, 457–466. [Google Scholar] [CrossRef] [PubMed]
  22. Zhang, H.J.; Luo, J.Z.; Lan, C.L.; Teng, X.; Ge, B.; Liu, J.Q.; Xie, H.X.; Yang, K.J.; Qin, C.J.; Zhou, X.; et al. Baicalin protects against hepatocyte injury caused by aflatoxin b(1) via the tp53-related ferroptosis pathway. Ecotoxicol. Environ. Saf. 2024, 281, 116661. [Google Scholar] [CrossRef] [PubMed]
  23. Zhang, N.Y.; Qi, M.; Gao, X.; Zhao, L.; Liu, J.; Gu, C.Q.; Song, W.J.; Krumm, C.S.; Sun, L.H.; Qi, D.S. Response of the hepatic transcriptome to aflatoxin b1 in ducklings. Toxicon 2016, 111, 69–76. [Google Scholar] [CrossRef]
  24. Ma, M.; Wang, Q.; Liu, Y.; Li, G.; Liu, L.; Wang, G.; Guo, Y.; Huang, S.; Ma, Q.; Ji, C.; et al. Bacillus cota laccase improved the intestinal health, amino acid metabolism and hepatic metabolic capacity of pekin ducks fed naturally contaminated afb(1) diet. J. Anim. Sci. Biotechnol. 2024, 15, 138. [Google Scholar] [CrossRef]
  25. GB 13078-2017; National Standard of the People’s Republic of China GB 13078-2017 Feed Hygiene Standards. Ministry of Agriculture and Rural Affairs of the People’s Republic of China: Beijing, China, 2025; Volume NY/T 2071.
  26. Park, S.W.; Lee, C.H.; Kim, Y.S.; Kang, S.S.; Jeon, S.J.; Son, K.H.; Lee, S.M. Protective effect of baicalin against carbon tetrachloride-induced acute hepatic injury in mice. J. Pharmacol. Sci. 2008, 106, 136–143. [Google Scholar] [CrossRef] [PubMed]
  27. Wang, Y.; Jia, Y.; Yang, X.; Liang, B.; Gao, H.; Yang, T. A potential role of baicalin to inhibit apoptosis and protect against acute liver and kidney injury in rat preeclampsia model. Biomed. Pharmacother. 2018, 108, 1546–1552. [Google Scholar] [CrossRef]
  28. Wang, H.; Zhang, Y.; Bai, R.; Wang, M.; Du, S. Baicalin attenuates alcoholic liver injury through modulation of hepatic oxidative stress, inflammation and sonic hedgehog pathway in rats. Cell Physiol. Biochem. 2016, 39, 1129–1140. [Google Scholar] [CrossRef]
  29. Ganguly, R.; Kumar, R.; Pandey, A.K. Baicalin provides protection against fluoxetine-induced hepatotoxicity by modulation of oxidative stress and inflammation. World J. Hepatol. 2022, 14, 729–743. [Google Scholar] [CrossRef]
  30. Chu, Y.; Wang, H.; Xu, X.; Ji, Y.; Zhao, Y.; Yu, Q.; Rajput, S.A.; Xue, Y.; Qi, D. Protective effect of lipoic acid on oxidative stress and tissue damage induced by aflatoxin b(1) in young laying hens. Toxins 2025, 17, 184. [Google Scholar] [CrossRef]
  31. Pożarska, A.; Karpiesiuk, K.; Kozera, W.; Czarnik, U.; Dąbrowski, M.; Zielonka, Ł. Afb1 toxicity in human food and animal feed consumption: A review of experimental treatments and preventive measures. Int. J. Mol. Sci. 2024, 25, 5305. [Google Scholar] [CrossRef]
  32. Karimi Torshizi, M.A.; Sedaghat, A. A consortium of detoxifying bacteria mitigates the aflatoxin b1 toxicosis on performance, health, and blood constituents of laying hens. Poult. Sci. 2023, 102, 102601. [Google Scholar] [CrossRef]
  33. Wang, Y.; Wu, J.; Wang, L.; Yang, P.; Liu, Z.; Rajput, S.A.; Hassan, M.; Qi, D. Epigallocatechin gallate and glutathione attenuate aflatoxin b(1)-induced acute liver injury in ducklings via mitochondria-mediated apoptosis and the nrf2 signalling pathway. Toxins 2022, 14, 876. [Google Scholar] [CrossRef]
  34. Taranu, I.; Hermenean, A.; Bulgaru, C.; Pistol, G.C.; Ciceu, A.; Grosu, I.A.; Marin, D.E. Diet containing grape seed meal by-product counteracts afb1 toxicity in liver of pig after weaning. Ecotoxicol. Environ. Saf. 2020, 203, 110899. [Google Scholar] [CrossRef]
  35. Ofori-Attah, E.; Hashimoto, M.; Oki, M.; Kadowaki, D. Therapeutic effect of natural products and dietary supplements on aflatoxin-induced nephropathy. Int. J. Mol. Sci. 2024, 25, 2849. [Google Scholar] [CrossRef]
  36. Yang, D.; Zhang, S.; Cao, H.; Wu, H.; Liang, Y.; Teng, C.B.; Yu, H.F. Detoxification of aflatoxin b(1) by phytochemicals in agriculture and food science. J. Agric. Food Chem. 2024, 72, 14481–14497. [Google Scholar] [CrossRef] [PubMed]
  37. Dai, C.; Tian, E.; Hao, Z.; Tang, S.; Wang, Z.; Sharma, G.; Jiang, H.; Shen, J. Aflatoxin b1 toxicity and protective effects of curcumin: Molecular mechanisms and clinical implications. Antioxidants 2022, 11, 2031. [Google Scholar] [CrossRef]
  38. Lumsangkul, C.; Kaewtui, P.; Huanhong, K.; Tso, K.H. Antioxidative and antimycotoxigenic efficacies of thunbergia laurifolia lindl. For addressing aflatoxicosis in cherry valley ducks. Toxins 2024, 16, 334. [Google Scholar] [CrossRef]
  39. Feng, G.D.; He, J.; Ao, X.; Chen, D.W. Effects of maize naturally contaminated with aflatoxin b1 on growth performance, intestinal morphology, and digestive physiology in ducks. Poult. Sci. 2017, 96, 1948–1955. [Google Scholar] [CrossRef] [PubMed]
  40. Wen, Y.Q.; Wang, Y.Z.; Zhao, C.X.; Zhao, B.Y.; Wang, J.G. Baicalin: An active natural product with potential medicinal values. J. Asian Nat. Prod. Res. 2025, 27, 1087–1111. [Google Scholar] [CrossRef]
  41. Zhang, Q.; Guo, S.; Ge, H.; Wang, H. The protective role of baicalin regulation of autophagy in cancers. Cytotechnology 2025, 77, 33. [Google Scholar] [CrossRef] [PubMed]
  42. Wang, R.; Zhang, K.; Liu, K.; Pei, H.; Shi, K.; He, Z.; Zong, Y.; Du, R. Protective effect of baicalin on chlorpyrifos-induced liver injury and its mechanism. Molecules 2023, 28, 7771. [Google Scholar] [CrossRef]
  43. Bao, M.; Ma, Y.; Liang, M.; Sun, X.; Ju, X.; Yong, Y.; Liu, X. Research progress on pharmacological effects and new dosage forms of baicalin. Vet. Med. Sci. 2022, 8, 2773–2784. [Google Scholar] [CrossRef]
  44. Wang, P.; Wang, Y.; Feng, T.; Yan, Z.; Zhu, D.; Lin, H.; Iqbal, M.; Deng, D.; Kulyar, M.F.; Shen, Y. Hedyotis diffusa alleviate aflatoxin b1-induced liver injury in ducks by mediating nrf2 signaling pathway. Ecotoxicol. Environ. Saf. 2023, 249, 114339. [Google Scholar] [CrossRef] [PubMed]
  45. Saghir, S.A.M.; Al Hroob, A.M.; Al-Tarawni, A.H.; Abdulghani, M.A.M.; Tabana, Y.; Aldhalmi, A.K.; Mothana, R.A.; Al-Yousef, H.M. Effect of lactiplantibacillus plantarum on the growth, hemato-biochemical, inflammation, apoptosis, oxidative stress markers, involved gens and histopathological alterations in growing rabbits challenged with aflatoxin b1. Poult. Sci. 2024, 103, 104002. [Google Scholar] [CrossRef] [PubMed]
  46. Chen, Y.; Yang, Y.; Wang, F.; Yang, X.; Yao, F.; Ming, K.; Yuan, W.; Zeng, L.; Liu, J. Antiviral effect of baicalin phospholipid complex against duck hepatitis a virus type 1. Poult. Sci. 2018, 97, 2722–2732. [Google Scholar] [CrossRef]
  47. Liang, S.; Deng, X.; Lei, L.; Zheng, Y.; Ai, J.; Chen, L.; Xiong, H.; Mei, Z.; Cheng, Y.C.; Ren, Y. The comparative study of the therapeutic effects and mechanism of baicalin, baicalein, and their combination on ulcerative colitis rat. Front. Pharmacol. 2019, 10, 1466. [Google Scholar] [CrossRef]
  48. Wang, Y.; Wang, X.; Li, Q. Aflatoxin b(1) in poultry liver: Toxic mechanism. Toxicon 2023, 233, 107262. [Google Scholar] [CrossRef] [PubMed]
  49. Wang, L.; Huang, Q.; Wu, J.; Wu, W.; Jiang, J.; Yan, H.; Huang, J.; Sun, Y.; Deng, Y. The metabolism and biotransformation of afb(1): Key enzymes and pathways. Biochem. Pharmacol. 2022, 199, 115005. [Google Scholar] [CrossRef]
  50. Chen, Y.; Li, R.; Chang, Q.; Dong, Z.; Yang, H.; Xu, C. Lactobacillus bulgaricus or lactobacillus rhamnosus suppresses nf-κb signaling pathway and protects against afb1-induced hepatitis: A novel potential preventive strategy for aflatoxicosis? Toxins 2019, 11, 17. [Google Scholar] [CrossRef]
  51. Li, X.; Lv, Z.; Chen, J.; Nepovimova, E.; Long, M.; Wu, W.; Kuca, K. Bacillus amyloliquefaciens b10 can alleviate liver apoptosis and oxidative stress induced by aflatoxin b1. Food Chem. Toxicol. 2021, 151, 112124. [Google Scholar] [CrossRef]
  52. Su, Q.; Pan, H.; Hong, P.; You, Y.; Wu, Y.; Zou, J.; Sun, J.; Rao, G.; Liao, J.; Tang, Z.; et al. Protective effect of curcumin against endoplasmic reticulum stress and lipid metabolism disorders in afb1-intoxicated duck liver. Mycotoxin Res. 2025, 41, 359–372. [Google Scholar] [CrossRef] [PubMed]
  53. Du, H.; Yang, K.; He, Z.; Su, L.; Tan, X.; Li, Z.; Song, W.; Cao, L.; Ma, Y. Tianjihuang compound alleviates aflatoxin b(1)-induced hepatic steatosis and fibrosis by targeting pparα-tgf-β pathway in ducklings. Poult. Sci. 2025, 104, 105006. [Google Scholar] [CrossRef] [PubMed]
  54. Feng, T.; Li, S.; Wang, P.; Zhu, D.; Xu, Z.; Wang, L.; Li, A.; Kulyar, M.F.; Shen, Y. Hepatoprotective effects of radix bupleuri extract on aflatoxin b1-induced liver injury in ducks. Ecotoxicol. Environ. Saf. 2024, 283, 116781. [Google Scholar] [CrossRef] [PubMed]
  55. Cui, Y.; Wang, Q.; Zhang, X.; Yang, X.; Shi, Y.; Li, Y.; Song, M. Curcumin alleviates aflatoxin b(1)-induced liver pyroptosis and fibrosis by regulating the jak2/nlrp3 signaling pathway in ducks. Foods 2023, 12, 1006. [Google Scholar] [CrossRef]
Figure 1. Histopathological changes in liver in ducklings induced by different doses of aflatoxin B1 (AFB1) (haematoxylin and eosin staining, 400 × magnification). (A) Control group; (B) 6 μg/kg body weight/day AFB1 group; (C) 12 μg/kg body weight/day AFB1 group; (D) 24 μg/kg body weight/day AFB1 group. The yellow arrows in the figure indicate hepatocyte granular degeneration. The blue arrow shows hepatocyte steatosis. The red arrow shows liver cell necrosis.
Figure 1. Histopathological changes in liver in ducklings induced by different doses of aflatoxin B1 (AFB1) (haematoxylin and eosin staining, 400 × magnification). (A) Control group; (B) 6 μg/kg body weight/day AFB1 group; (C) 12 μg/kg body weight/day AFB1 group; (D) 24 μg/kg body weight/day AFB1 group. The yellow arrows in the figure indicate hepatocyte granular degeneration. The blue arrow shows hepatocyte steatosis. The red arrow shows liver cell necrosis.
Animals 15 02325 g001
Figure 2. The effect of baicalin on liver histopathological changes in ducklings exposed to AFB1 (haematoxylin and eosin staining, 400× magnification). (A) control group; (B) 12 μg/kg body weight/day AFB1; (C) 12 μg/kg body weight/day AFB1 + 25 mg/kg body weight/day baicalin; (D) 12 μg/kg body weight/day AFB1 + 50 mg/kg body weight/day baicalin; (E) 12 μg/kg body weight/day AFB1 + 100 mg/kg body weight/day baicalin. The yellow arrow shows hepatocyte granular degeneration. The blue arrow shows hepatocyte steatosis. The red arrow shows liver cell necrosis.
Figure 2. The effect of baicalin on liver histopathological changes in ducklings exposed to AFB1 (haematoxylin and eosin staining, 400× magnification). (A) control group; (B) 12 μg/kg body weight/day AFB1; (C) 12 μg/kg body weight/day AFB1 + 25 mg/kg body weight/day baicalin; (D) 12 μg/kg body weight/day AFB1 + 50 mg/kg body weight/day baicalin; (E) 12 μg/kg body weight/day AFB1 + 100 mg/kg body weight/day baicalin. The yellow arrow shows hepatocyte granular degeneration. The blue arrow shows hepatocyte steatosis. The red arrow shows liver cell necrosis.
Animals 15 02325 g002
Table 1. The effect of aflatoxin B1 (AFB1) intake dose on growth indicators of ducklings. In each row, different lowercase superscript letters indicate a significant difference (p < 0.05), while the same lowercase superscript levels indicate no significant difference (p > 0.05). ADG: average daily gain; ADFI: average daily feed intake; FCR: feed-to-gain ratio. “/” indicates there was no separate cage feeding, and there was only one data point for ADFI and FCR for the group.
Table 1. The effect of aflatoxin B1 (AFB1) intake dose on growth indicators of ducklings. In each row, different lowercase superscript letters indicate a significant difference (p < 0.05), while the same lowercase superscript levels indicate no significant difference (p > 0.05). ADG: average daily gain; ADFI: average daily feed intake; FCR: feed-to-gain ratio. “/” indicates there was no separate cage feeding, and there was only one data point for ADFI and FCR for the group.
IndicatorsControlAFB1 (μg/kg Body Weight/Day)SEMp Value
61224
ADG (g/day)28.64 a27.57 a24.29 b21.74 b0.7790.001
ADFI (g/day)58.6656.0652.8750.77//
FCR1.982.032.172.31//
Table 2. The effect of baicalin on growth performance of aflatoxin B1 (AFB1)-challenged ducklings. AFB1: 12 μg/kg body weight/day AFB1; 25BA: 12 μg/kg body weight/day AFB1 + 25 mg/kg body weight/day baicalin; 50BA: 12 μg/kg body weight/day AFB1 + 50 mg/kg body weight/day baicalin; 100BA: 12 μg/kg body weight/day AFB1 + 100 mg/kg body weight/day baicalin. ADG: average daily gain; ADFI: average daily feed intake; FCR: feed-to-gain ratio.
Table 2. The effect of baicalin on growth performance of aflatoxin B1 (AFB1)-challenged ducklings. AFB1: 12 μg/kg body weight/day AFB1; 25BA: 12 μg/kg body weight/day AFB1 + 25 mg/kg body weight/day baicalin; 50BA: 12 μg/kg body weight/day AFB1 + 50 mg/kg body weight/day baicalin; 100BA: 12 μg/kg body weight/day AFB1 + 100 mg/kg body weight/day baicalin. ADG: average daily gain; ADFI: average daily feed intake; FCR: feed-to-gain ratio.
IndicatorsControl
(A)
AFB1
(B)
25BA
(C)
50BA
(D)
100BA
(E)
SEMp Value
A vs. BC vs. BD vs. BE vs. B
ADG (g/day)26.4823.1024.1626.6827.840.5310.0050.9420.1620.015
ADFI (g/day)51.6049.8344.9948.1448.801.1180.5720.4740.9690.995
FCR1.962.131.861.841.750.0500.0740.1730.1410.035
Table 3. The effect of baicalin on serum biochemical parameters of aflatoxin B1 (AFB1) exposed ducklings. AFB1: 12 μg/kg body weight/day AFB1; 25BA: 12 μg/kg body weight/day AFB1 + 25 mg/kg body weight/day baicalin; 50BA: 12 μg/kg body weight/day AFB1 + 50 mg/kg body weight/day baicalin; 100BA: 12 μg/kg body weight/day AFB1 + 100 mg/kg body weight/day baicalin. ALB: albumin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: gamma-glutamyl transferase.
Table 3. The effect of baicalin on serum biochemical parameters of aflatoxin B1 (AFB1) exposed ducklings. AFB1: 12 μg/kg body weight/day AFB1; 25BA: 12 μg/kg body weight/day AFB1 + 25 mg/kg body weight/day baicalin; 50BA: 12 μg/kg body weight/day AFB1 + 50 mg/kg body weight/day baicalin; 100BA: 12 μg/kg body weight/day AFB1 + 100 mg/kg body weight/day baicalin. ALB: albumin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: gamma-glutamyl transferase.
IndicatorsControl
(A)
AFB1
(B)
25BA
(C)
50BA
(D)
100BA
(E)
SEMp Value
A vs. BC vs. BD vs. BE vs. B
ALB (g/L)11.7610.4311.7711.8312.240.2140.0400.0270.0300.005
AST (U/L)22.0035.1322.6020.5021.002.0780.0130.0100.0020.005
ALT (U/L)49.2563.0044.3049.8644.702.2570.0150.0020.0260.003
GGT (U/L)4.407.105.005.334.700.1930.0200.0630.1600.027
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lu, Q.; Zhang, X.; Zhang, J.; Wang, X.; Wen, D.; Guo, P.; Xiong, J.; Qiu, Y. Effects of Dietary Baicalin on Aflatoxin B1-Induced Growth Performance and Liver Health in Ducklings. Animals 2025, 15, 2325. https://doi.org/10.3390/ani15162325

AMA Style

Lu Q, Zhang X, Zhang J, Wang X, Wen D, Guo P, Xiong J, Qiu Y. Effects of Dietary Baicalin on Aflatoxin B1-Induced Growth Performance and Liver Health in Ducklings. Animals. 2025; 15(16):2325. https://doi.org/10.3390/ani15162325

Chicago/Turabian Style

Lu, Qirong, Xue Zhang, Jie Zhang, Xinyue Wang, Defeng Wen, Pu Guo, Jianglin Xiong, and Yinsheng Qiu. 2025. "Effects of Dietary Baicalin on Aflatoxin B1-Induced Growth Performance and Liver Health in Ducklings" Animals 15, no. 16: 2325. https://doi.org/10.3390/ani15162325

APA Style

Lu, Q., Zhang, X., Zhang, J., Wang, X., Wen, D., Guo, P., Xiong, J., & Qiu, Y. (2025). Effects of Dietary Baicalin on Aflatoxin B1-Induced Growth Performance and Liver Health in Ducklings. Animals, 15(16), 2325. https://doi.org/10.3390/ani15162325

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop